Avanos Medical Inc (NYSE:AVNS)
$ 23.77 0.28 (1.19%) Market Cap: 1.09 Bil Enterprise Value: 1.22 Bil PE Ratio: 139.82 PB Ratio: 0.89 GF Score: 73/100

Avanos Medical Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 12:30AM GMT
Release Date Price: $28.92 (+3.69%)
Caroline Borowski

Thank you all. My name is Caroline Borowski, and I am part of the JPMorgan Healthcare Group here. So I would like to introduce Joe Woody, the Chief Executive Officer of Avanos.

Joseph F. Woody
Avanos Medical, Inc. - CEO & Director

Thank you, Caroline. Good afternoon, everyone. Appreciate everyone here live in the room, and those of you that are on the webcast, appreciate your interest in Avanos.

It's great to be live again at JPMorgan, and we've had a good meeting so far. I have 3 things that I want to do today. One is update on our portfolio and talk a little bit about our vision. The second is we want to give an update on 2022. And third and most importantly, we want to talk about a transformation, a 3-year transformation in our business that we believe is going to create a lot of value.

As always, I will be talking about forward-looking information. We can't guarantee that the projections come out the way as planned. There are certainly lots of risks and uncertainties in the presentation. As well, we utilize non-GAAP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot